wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26865314-D1C68A99-2BEE-4F5A-AC03-A9D277F8831A
Q26865314-D1C68A99-2BEE-4F5A-AC03-A9D277F8831A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26865314-D1C68A99-2BEE-4F5A-AC03-A9D277F8831A
Treatment of Refractory Chronic Urticaria
P2860
Q26865314-D1C68A99-2BEE-4F5A-AC03-A9D277F8831A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26865314-D1C68A99-2BEE-4F5A-AC03-A9D277F8831A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69269b4cba861faf015ca34e87c287f2ed8cf7cb
P2860
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.